Janwillem Naesens

Chief Executive Officer at Convert Pharmaceuticals SA

Janwillem Naesens

Janwillem Naesens

Chief Executive Officer at Convert Pharmaceuticals SA

Biography

Currently, Janwillem Naesens occupies the position of Chief Executive Officer for Convert Pharmaceuticals SA. Mr. Naesens is also on the board of NormOxys, Inc. and Tusk Therapeutics Ltd. and Partner at DROIA SA. In the past he occupied the position of Investment Manager at Waterland Private Equity NV. He received an MBA from INSEAD and an undergraduate degree from Katholieke Universiteit Leuven.

Overview
Career Highlights

Convert Pharmaceuticals SA

RelSci Relationships

60

Number of Boards

3

Relationships
RelSci Relationships are individuals Janwillem Naesens likely has professional access to. A relationship does not necessarily indicate a personal connection.

Director at Gimv NV

Relationship likelihood: Strong

Co-Founder at NormOxys, Inc.

Relationship likelihood: Strong

Co-Founder at NormOxys, Inc.

Relationship likelihood: Strong

Co-Founder at NormOxys, Inc.

Relationship likelihood: Strong

Chief Operating Officer at Merck KGaA

Relationship likelihood: Strong

Operating Partner at Advent International Corp.

Relationship likelihood: Strong

Managing Partner at Biogeneration Management BV

Relationship likelihood: Strong

Co-Founder & Managing Partner at Aglaia BioMedical Ventures BV

Relationship likelihood: Strong

Founder at Alzheon, Inc.

Relationship likelihood: Strong

Investment Manager at Chemelot Ventures BV

Relationship likelihood: Strong

Paths to Janwillem Naesens
Potential Connections via
Relationship Science
You
Janwillem Naesens
Chief Executive Officer at Convert Pharmaceuticals SA
Career History
Partner
2013 - Current
Chief Executive Officer
Current

Convert Pharmaceuticals SA provides preclinical stage drug development services. Its product hypoxia activated prodrug (HAP) is a therapeutic obstacle as it promotes the development of resistance to conventional anti-cancer treatments. The company was founded by Philippe Lambin, Nicolas Geuens, and Paul Tulcinsky on February 24, 2017 and is headquartered in Liege, Belgium.

Investment Manager
2008 - 2013
Boards & Committees
Member-Supervisory Board
Current
Director
Current
Director
Current
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Janwillem Naesens. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Janwillem Naesens's profile does not indicate a business or promotional relationship of any kind between RelSci and Janwillem Naesens.